Drug developers are rapidly adopting three-dimensional (3D) cell cultures for drug screening since they provide a more physiologically relevant environment than two-dimensional cell cultures to screen compounds. Spheroids are a simple and well characterized, in vitro tumor model system. However, manual manipulations of these spheroid cultures can be laborious and challenges are amplified as sample throughput increases. This webinar, co-presented by 3D Biomatrix and Beckman Coulter, discussed automation of 3D cell culture for screening by imaging and flow cytometry.

Learning Objectives:

• Understand why drug developers are rapidly adopting three-dimensional (3D) cell cultures for drug screening
• Learn about automation of 3D cell culture for screening by imaging and flow cytometry